Ultrasound-guided foam sclerotherapy is a safe and clinically effective treatment for superficial venous reflux

Andrew Bradbury, G Bate, K Pang, Katy Darvall, Donald Adam

Research output: Contribution to journalArticle

69 Citations (Scopus)


Objective: To test the hypothesis that ultrasound-guided foam sclerotherapy (UGFS) is a safe and durable treatment for superficial venous reflux (SVR) associated with CEAP clinical grade 2-6 disease. Methods: This was an interrogation of a prospectively gathered computerized database. Results: Between March 23, 2004 and December 31, 2009, 977 patients (1252 legs) underwent UGFS for unilateral (702 legs) or bilateral (550 legs) SVR in association with CEAP clinical grade 2-3 (n = 868), 4 (n = 232), or 5/6 (n = 152) disease. The following reflux in 1417 venous segments was treated: primary great saphenous vein (GSV) (n = 745); recurrent GSV (n = 286), primary small saphenous vein (SSV) (n = 189), recurrent SSV (n = 50); primary anterior accessory saphenous vein (AASV) (n = 93); recurrent AASV (n = 46); vein of the popliteal fossa (VOPF) (n = 5), and Giacomini vein (GV) (n = 3). Three hundred forty-eight legs (27.8%) had undergone previous surgery. Three patients suffered post-UGFS deep vein thrombosis (DVT) and one a pulmonary embolus (PE), all within the first month (0.4% venous thrombo-cmbolic complication rate). Five patients (0.5%) had transient visual disturbance at the time of, or shortly after, treatment. No other neurologic or serious complications were reported. During a mean (range) follow-up of 28 (
Original languageEnglish
Pages (from-to)939-945
Number of pages7
JournalJournal of Vascular Surgery
Issue number4
Publication statusPublished - 1 Oct 2010


Dive into the research topics of 'Ultrasound-guided foam sclerotherapy is a safe and clinically effective treatment for superficial venous reflux'. Together they form a unique fingerprint.

Cite this